ZY
NASDAQ · ZYBT
Zhengye Biotechnology Holding Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$1.38
Up+$0.02 (+1.09%)
Updated Sep 16, 2026, 4:19 PM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 94.78M
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- $0.62 – $8.01
- Volume
- 28.53K
- Avg. volume
- 423.1K
Price performance
ZYBT price history
1M range · 20 trading sessions · Daily adjusted prices
ZYBT closed at $1.38 after 20 trading sessions, down 9.80% for the selected period.
- Last close
- $1.38
- Period change
- -9.80%
- Period low
- $1.38
- Period high
- $2.04
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.41 | $1.41 | $1.36 | $1.38 | 28.53K |
| Sep 14, 2026 | $1.55 | $1.55 | $1.40 | $1.42 | 55.32K |
| Sep 11, 2026 | $1.55 | $1.62 | $1.55 | $1.55 | 25.01K |
| Sep 10, 2026 | $1.55 | $1.625 | $1.55 | $1.59 | 45.96K |
| Sep 9, 2026 | $1.56 | $1.64 | $1.56 | $1.57 | 39.53K |
| Sep 8, 2026 | $1.60 | $1.61 | $1.56 | $1.58 | 30.36K |
| Sep 4, 2026 | $1.66 | $1.71 | $1.60 | $1.61 | 34.13K |
| Sep 3, 2026 | $1.65 | $1.68 | $1.5701 | $1.63 | 24.69K |
| Sep 2, 2026 | $1.57 | $1.68 | $1.57 | $1.63 | 54.64K |
| Sep 1, 2026 | $1.74 | $1.79 | $1.63 | $1.65 | 38.95K |
| Aug 31, 2026 | $1.70 | $1.78 | $1.70 | $1.73 | 31.01K |
| Aug 28, 2026 | $1.81 | $1.81 | $1.66 | $1.73 | 37.43K |
| Aug 27, 2026 | $1.80 | $1.8411 | $1.75 | $1.76 | 46.33K |
| Aug 26, 2026 | $1.85 | $1.90 | $1.82 | $1.83 | 34.25K |
| Aug 25, 2026 | $1.91 | $2.01 | $1.86 | $1.89 | 42.85K |
| Aug 24, 2026 | $2.00 | $2.11 | $1.85 | $1.95 | 147.44K |
| Aug 21, 2026 | $1.85 | $2.20 | $1.85 | $2.04 | 279.16K |
| Aug 20, 2026 | $1.81 | $1.95 | $1.77 | $1.89 | 200.26K |
| Aug 19, 2026 | $1.57 | $2.1553 | $1.54 | $1.85 | 1.66M |
| Aug 18, 2026 | $1.52 | $1.6294 | $1.50 | $1.53 | 130.1K |
Latest ZYBT news
The latest Smart Investors Daily articles mentioning ZYBT.
Stock researchResearch & News · SEC Filings
Loading stock research…
